Mutants of the autonomous parvovirus minute virus of mice (MVM) strains MVM(p) and MVM(i) that either fail to produce or produce a truncated NS2 protein, were deficient in the production of infectious virus and attained lower levels of viral DNA synthesis than wildtype virus following infection of a series of normal and transformed murine cell lines. Mutant virus growth and the levels of DNA replication were similar to those of wild-type virus in the rat, hamster and human lines tested. These results suggest that the requirement of NS2 for the growth of MVM is murine species-specific.
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The autonomous rodent parvoviruses encode two nonstructural proteins, the 83K phosphoprotein NS1 and the 23K to 25K phosphoprotein NS2 (reviewed in Cotmore & Tattersall, 1987) . NS1 is a well-studied, multifunctional protein localized to the nucleus that is required for viral DNA replication and gene expression (reviewed in Cotmore & Tattersall, 1987) . However, the role of NS2 during virus replication has only just begun to be determined. Analysis of mutants of the minute virus of mice (MVM) MVM(p) (Naeger et al., 1990 ) and H1 (Li & Rhode, 1991) strains that either fail to synthesize or synthesize a truncated NS2 molecule have identified a role for NS2 in the accumulation of viral DNA replication intermediates and in efficient virus production. Interestingly, the requirement for NS2 has been shown to be host cell-specific.
In this report we characterize the host range of selected MVM NS2 mutants more fully and demonstrate that NS2 is required for efficient MVM replication in murine cells. NS2 mutations were also generated in the lymphotropic strain MVM(i), and these mutants were also restricted for growth in the murine lymphocyte lines $49 and EL4.
The genetic map of MVM, including the positions of the mutations in the two NS2 mutants used in the present study, is presented in Fig. 1 . Previous results have indicated that MVM(p) mutants deficient in NS2 (including NS2-2018) are significantly more restricted for growth in murine A9 cells than on the simian virus 40 (SV40)-transformed human fibroblast line NB324K (Naeger et al., 1990) . To define the host range of MVM NS2 mutants more completely, we initially assayed the ability of MVM(p) NS2-2018 to produce infectious virus in various murine and non-murine cell lines. Three normal murine lines, A9, an L cell derivative (Littlefield, 1964 ; from P. Tattersall, Yale University, New Haven, Conn., U.S.A.), NIH3T3 (from N. Bouck, Northwestern University, Chicago, Ill., U.S.A.; originally from D. Nathans, Johns Hopkins University, Baltimore, Md., U.S.A.) and C127 (from D. DiMaio, Yale University), and three transformed murine cell lines [3T6, polyomavirus-transformod NIH3T3 (py3T3) and SV40-transformed NIH3T3 (sv3T3), obtained from W. R. Folk, University of Missouri-Columbia, Columbia, Mo., U.S.A.)] were tested (the normal NIH3T3 line used was not the immediate parent of the transformed NIH3T3 cell lines; the parent cell line was unavailable). A normal rat cell line (Rat2, from S. Rhode III, University of Nebraska, Omaha, Ne., U.S.A.), a transformed rat cell line [srcFR3T3 (Salome et al., 1990) , from J. Rommelaere, Universit6 Libre de Bruxelles, Belgium], the hamster cell line BHK and the SV40-transformed human cell line NB324K (Tattersall & Bratton, 1983) were also tested.
Since NS2-2018 virus produces very small plaques, to ensure that the virus inputs were equal wild-type and mutant infections were initially equilibrated by choosing the appropriate wild-type virus m.o.i., as determined by plaque assay, and adjusting the mutant virus m.o.i, such that the amount of input ssDNA, as detected by Southern hybridization (Tullis et al., 1988) , was equal.
Typically, when NS2-2018 virus plaque titres were matched to those of wild-type virus, their ssDNA content was found to be within two-to three-fold, indicating that there was not a substantial fluctuation in the particle-toinfectivity ratio of this mutant. Input plaque assay titres 0001-0765 © 1992 SGM Fig. 1 . A map depicting the three main MVM transcript families (R1, R2 and R3) in relation to the 5149 nucleotide genome, the proteins encoded (NS 1, NS2 and VP 1/2, respectively), the ORFs encoding these proteins and the approximate location of the mutations in the NS2 mutants used in this study (described in the text). were subsequently verified and adjusted if necessary by the in situ infectious centre assay described below.
The amount of NS2 mutant virus generated in 72 h and in 24 h in the presence of neuraminidase (0-05 units/ml of medium to assay a single burst cycle) was determined after infection at a multiplicity of 2. Virus yields from these experiments, as assayed by plaque assay on NB324K cells, demonstrated that the production of mutant virus was restricted in murine cells, compared to that of wild-type virus (Table 1) . In all murine cell lines tested, the amount of mutant virus produced within a single burst cycle was reduced at least 15-fold compared to that produced by a parallel wild-type virus infection. By 72 h, the reduction in virus yield from A9 cells had increased to approximately 50-fold, and to as high as 104-fold in NIH3T3 cells (Table 1) . For A9 cells this represented an amplification of NS2-2018 virus of approximately 50-fold by 72 h, whereas in the parallel infection with wild-type virus amplification was approximately 1000-fold. In the other murine cell lines tested, the ratios listed represent only an approximately 10-fold amplification of mutant virus. In contrast, NS2 mutant virus growth in a single burst cycle in the rat and hamster lines examined was less than fivefold reduced from wildtype virus levels. For BHK cells, by 72 h NS2 mutant and wild-type virus yields had become essentially equivalent, whereas in the rat lines tested the growth of the NS2 mutant virus was reduced by less than 10-fold compared to that of wild-type virus. In parallel infections, SV40-transformed human NB324K cells were also shown to support similar 104-fold increases of both NS2-2018 and wild-type virus production at 72 h (data not shown), as has been observed previously (Naeger et al., 1990) .
The levels of mutant and wild-type virus DNA replication were also analysed in murine and non-murine cell lines. Following infection at a multiplicity of 1, A9 and NB324K cells were synchronized by a combined isoleucine deprivation/aphidicolin procedure (Cotmore and Tattersall, 1987; Clemens & Pintel, 1988) and DNA replication was assayed using a quantitative, dispersed cell hybridization assay (Yakobson et al., 1989) in which infected cells were trapped on nitrocellulose circles and hybridized with 32p-labelled cloned MVM DNA as described previously (Tullis et al., 1988) . By 48 h postinfection, murine A9 cells were able to support only a very limited amount of NS2-2018 virus DNA replication as assayed by this method, approximately 100-fold less than that of wild-type virus. In contrast, human NB324K cells supported levels of NS2-2018 virus DNA replication similar to those of wild-type virus (data not shown).
NS2-2018 virus DNA replication in various cell types was also assayed by hybridization of 32p-labelled MVM DNA to infected cell monolayers transferred to nitrocellulose exactly as described by Yakobsen et al. (1989) . This assay displays the magnitude of virus DNA replication within individual infectious centres. Various normal and transformed murine cells, as well as rat, hamster and transformed human cells, were infected with NS2-2018 or wild-type virus at eqivalent multiplicities; representative filters are shown in Fig. 2 . In murine A9 cells (Fig. 2a) , the increase in DNA replication over time in each NS2-2018 virus-generated infectious centre was significantly less than that for wild-type MVM, although the number of infectious centres and the kinetics of their appearance were similar. Similar deficiencies were also seen for infections of C 127, sv3T3, NIH3T3, the bovine papillomavirus-transformed C127 line ID13 (from P. Howley, NIH, Washington, D.C., U.S.A.) and py3T3 (data not shown) cells. Approximately the same number of infectious centres were established by the mutant and wild-type viruses in murine cells, and they appear with approximately the same kinetics, but DNA amplification within these centres does not proceed at the same rate, further confirming the block to NS2 mutant MVM(p) DNA replication within murine cells. In contrast, in SV40-transformed human NB324K (Fig. 2b ) and rat FR3T3 (Fig. 2c) cells, the increase in DNA replication within the individual mutant virus-generated infectious centres was similar to that generated with wild-type virus. Levels of replication similar to that of wild-type virus were also seen in these assays following infection of BHK, Rat 2 and src-transformed rat FR3T3 cells (data not shown).
MVM(p) and MVM(i) are allotropic variants of MVM that display reciprocal tissue-specific host ranges (McMaster et al., 1981; Tattersall & Bratton, 1983; reviewed in Cotmore & Tattersall, 1987) . MVM(p) grows well in murine fibroblasts but not murine T lymphocyte lines, whereas MVM(i) grows well in murine T lymphocytes but not murine fibroblasts. To examine the requirement for NS2 for growth of MVM(i) in cultured cell lines, the following two mutants were constructed. In the first, MVM(i)NS2-2019, a G--,T transversion was constructed at nucleotide 2019 using oligonucleotide mutagenesis, exactly as was used previously to construct the analogous mutants of MVM(p) (Naeger et al., 1990) except that the MVM(i) HaelII fragment (nucleotides 1854 to 2378) was used as the mutation template, together with a mutagenic oligonucleotide of the MVM(i) sequence. After mutagenesis, the mutant MVM(i) BstEII-XhoI fragment (nucleotides 1886 to 2072) was inserted into the MVM(i) infectious plasmid clone and the inserted fragment was completely sequenced to assure the absence of additional mutations. The change at nucleotide 2019, which is analogous to that of the NS2-2018 mutant of MVM(p), introduces an ochre termination signal in open reading frame (ORF) 2, causing translation of NS2 to terminate after 94 codons, and generates a degenerate change in ORF 3, leaving NS1 unaltered. In the second mutant, MVM(i) NS2-1990 , an A--,C transversion was introduced at nucleotide 1990. This change is analogous to the NS2-1989 mutation in MVM(p) (Naeger et al., 1990) , which has been shown to destroy the splice acceptor site for viral mRNA R2 (which encodes NS2), preventing its production, but leaving NS1 unaltered.
Virus growth curves, constructed as described for the MVM(p) mutants, show that in the normal murine host for MVM(i), $49 cells, MVM(i)NS2-2019 produced approximately 15-fold less virus than wild-type virus in a single burst cycle, whereas by 72 h, the total accumulation of the mutant virus was approximately 500-fold less than that of wild-type virus (Table 2) , representing a less than 10-fold amplification of the mutant virus during Previous analysis of MVM(p) and H1 mutants that either fail to produce or produce a truncated NS2 protein has demonstrated a role for this protein in both genome replication and efficient virus production in a host cellspecific manner (Naeger et al., 1990; Li & Rhode, 1991) . 
